PT-141 (Bremelanotide) (10mg)
$45.00
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called bremelanotide, this synthetic cyclic heptapeptide is a melanocortin receptor agonist studied in relation to MC1R, MC3R, and MC4R signaling.accessdata.fda+2
-
Product: PT-141 (Bremelanotide)
-
Alternative name: Bremelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₅₀H₆₈N₁₄O₁₀
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
PT-141 (Bremelanotide) (10mg) for Laboratory Research
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratories investigating melanocortin receptor signaling, central nervous system pathways, and sexual-processing research. Bremelanotide is a synthetic cyclic heptapeptide and a non-selective agonist of melanocortin receptors.accessdata.fda+2
For laboratories looking to buy PT-141, this listing identifies a 10 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
PT-141 Product Information
| Property | Listing information |
|---|---|
| Product name | PT-141 (Bremelanotide) |
| Alternative name | Bremelanotide |
| Listed quantity | 10 mg |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.
PT-141 Reference Molecular Characteristics
The following characteristics describe the PT-141 reference structure. They are not analytical confirmation of an individual commercial batch.
| Reference characteristic | Information |
|---|---|
| Peptide length | 7 residues |
| Reference sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular formula | C₅₀H₆₈N₁₄O₁₀ |
| Approximate molecular weight | 1025.2 g/mol |
| CAS number | 189691-06-3 |
| Chemical class | Cyclic heptapeptide melanocortin agonist |
The sequence, molecular formula, molecular weight, and CAS number are documented in the PubChem Bremelanotide reference record and in the FDA Vyleesi label. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations.accessdata.fda+2
PT-141 and MC4R Research
Bremelanotide is a melanocortin receptor agonist that non-selectively activates several receptor subtypes with the following order of potency: MC1R, MC4R, MC3R, MC5R, MC2R. At therapeutic dose levels, binding to MC1R and MC4R is most relevant.accessdata.fda+1
A randomized, double-blinded, placebo-controlled, crossover clinical study evaluated the effects of MC4R agonism on sexual brain processing in 31 premenopausal women with hypoactive sexual desire disorder. The investigators reported that MC4R agonism significantly increased self-reported sexual desire for up to 24 hours post administration, compared with placebo.
Read the primary MC4R agonism study for the experimental design and limitations.
Cavernosal-Tissue Research
Research has explored the possible involvement of the nitric oxide-cyclic guanosine monophosphate pathway in the action of melanocortin agonists on erectile function. The investigators reported that disrupting pudendal nerves or inhibiting nitric oxide synthesis diminished melanocortin-agonist-induced increases in pressure within cavernosal tissues in anesthetized mouse models.accessdata.fda+1
These findings apply to a specific animal model and exposure protocol. They do not establish that a commercial PT-141 batch induces erections, improves sexual function, or produces a cosmetic effect in humans.accessdata.fda+1
Research Limitations
Published PT-141 research examines receptor signaling, cell-based assays, and limited clinical studies in premenopausal women with hypoactive sexual desire disorder. It does not establish that PT-141 treats erectile dysfunction, obesity, cell death, or any other condition.accessdata.fda+2
Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.
Documentation and Batch Verification
Before selecting PT-141 (Bremelanotide) (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.
For inquiries, provide “PT-141 (Bremelanotide) (10mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About PT-141 (Bremelanotide) (10mg)
What is PT-141?
PT-141 is bremelanotide, a synthetic cyclic heptapeptide and a non-selective agonist of melanocortin receptors.accessdata.fda+1
Is PT-141 the same as bremelanotide?
Yes. PT-141 and bremelanotide refer to the same molecule.pubchem.ncbi.nlm.nih+1
Does PT-141 activate MC4R?
Bremelanotide is a melanocortin receptor agonist that non-selectively activates several receptor subtypes, including MC4R. This does not establish that a commercial batch activates MC4R in humans.accessdata.fda+1
What does the 10mg designation mean?
It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
PT-141 (Bremelanotide) (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
ACE-031 (1mg)
ACE-031 (1mg) is offered by Biotech Peptides for laboratory and analytical research. ACE-031 is a soluble fusion protein comprising the extracellular domain of activin receptor type IIB fused to the Fc portion of human IgG1, studied in relation to myostatin signaling and muscle-mass regulation. 1198
-
Product: ACE-031
-
Alternative name: Ramatercept
-
Listed quantity: 1 mg
-
Reference molecular weight: 77.24 kDa
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Decapeptide-12 (200mg)
Decapeptide-12 (200mg), also known by its sequence YRSRKYSSWY, is a synthetic ten-amino-acid peptide investigated for its interaction with tyrosinase and its role in experimental melanogenesis research. Published studies have examined its effects on tyrosinase activity and melanin content in laboratory models. Listed for laboratory and analytical research.
FOXO4-DRI (Proxofim) (10mg)
FOXO4-DRI (Proxofim) (10mg) is offered by Biotech Peptides for laboratory and analytical research. FOXO4-DRI is a synthetic D-retro-inverso peptide, also called Proxofim, studied in relation to FOXO4-p53 signaling and senescent-cell apoptosis. 1241
-
Product: FOXO4-DRI
-
Alternative name: Proxofim
-
Listed quantity: 10 mg
-
Reference molecular formula: C₂₂₈H₃₈₈N₈₆O₆₄
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Melanotan 1 (10mg)
Melanotan 1 (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called afamelanotide, this synthetic 13-residue analogue of alpha-melanocyte-stimulating hormone has been studied in relation to melanocortin receptor signaling and melanin production.pmc.ncbi.nlm.nih+1
-
Product: Melanotan 1
-
Alternative name: Afamelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₇₈H₁₁₁N₂₁O₁₉
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) | Biotech Peptides
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) is a synthetic, lipid-modified tripeptide listed for laboratory and analytical research involving peptide chemistry and skin-related research models.
Also known as Palmitoyl-Gly-His-Lys, Pal-GHK consists of a palmitoyl group attached to the N-terminus of the GHK tripeptide sequence. It has been investigated in research involving extracellular matrix components and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Peptide sequence: Gly-His-Lys (GHK)
- N-terminal modification: Palmitoyl group
- Molecular formula: C₃₀H₅₄N₆O₅
- Molecular weight: 578.8 g/mol
- CAS number: 147732-56-7
- Common name: Palmitoyl Tripeptide-1
TB-500 (Thymosin Beta-4) (10mg)
TB-500 (Thymosin Beta-4) (10mg) is offered by Biotech Peptides for laboratory and analytical research. TB-500 is a synthetic 43-residue peptide derived from thymosin beta-4, studied in relation to cell migration, angiogenesis, and wound-repair signaling. 1153
-
Product: TB-500
-
Full name: Thymosin Beta-4
-
Listed quantity: 10 mg
-
Reference molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Thymalin (25mg)
Thymalin (25mg) is offered by Biotech Peptides for laboratory and analytical research. Thymalin is a synthetic 9-residue peptide, also called thymulin, studied in relation to immune modulation, cytokine signaling, and neuroendocrine pathways. 1226
-
Product: Thymalin
-
Alternative name: Thymulin
-
Listed quantity: 25 mg
-
Reference molecular formula: C₃₃H₅₄N₁₂O₁₅
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
